Preliminary Results of a Phase II Study of Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC

Elamin, Y; Robichaux, J; Heymach, J

JOURNAL OF THORACIC ONCOLOGY, 2017; 12 (8): S1536